Cargando…

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is one of the most common childhood psychiatric disorders and negatively impacts caregivers’ lives. Factors including barriers to accessing care, dissatisfaction with support services, and lack of caregiver resources may contribute to this....

Descripción completa

Detalles Bibliográficos
Autores principales:	Fridman, Moshe, Banaschewski, Tobias, Sikirica, Vanja, Quintero, Javier, Chen, Kristina S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384740/ https://www.ncbi.nlm.nih.gov/pubmed/28408828 http://dx.doi.org/10.2147/NDT.S128752

Ejemplares similares

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
por: Fridman, Moshe, et al.
Publicado: (2017)

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
por: Fridman, Moshe, et al.
Publicado: (2017)

Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
por: Flood, Emuella, et al.
Publicado: (2016)

Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns
por: Hodgkins, Paul, et al.
Publicado: (2013)

Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Sikirica, Vanja, et al.
Publicado: (2013)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
por: Lachaine, Jean, et al.
Publicado: (2016)

Comparison of Quality of Life, Productivity, Functioning and Self-Esteem in Adults Diagnosed With ADHD and With Symptomatic ADHD
por: Pawaskar, Manjiri, et al.
Publicado: (2019)

Current issues around the pharmacotherapy of ADHD in children and adults
por: Meijer, Willemijn M., et al.
Publicado: (2009)

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics
por: Sikirica, Vanja, et al.
Publicado: (2012)

The female side of pharmacotherapy for ADHD—A systematic literature review
por: Kok, Francien M., et al.
Publicado: (2020)

Balancing access to ADHD medication
Publicado: (2023)

Pharmacotherapy of ADHD in Adults With Autism Spectrum Disorder: Effectiveness and Side Effects
por: Muit, J. J., et al.
Publicado: (2019)

Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
por: Lee, Sang-Min, et al.
Publicado: (2021)

Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD
por: Coghill, David R., et al.
Publicado: (2017)

The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD
por: Wettstein, R., et al.
Publicado: (2022)

The ADHD Concomitant Difficulties Scale (ADHD-CDS), a Brief Scale to Measure Comorbidity Associated to ADHD
por: Fenollar-Cortés, Javier, et al.
Publicado: (2016)

Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case
por: Le, Hoa H., et al.
Publicado: (2013)

Advancing services for adult ADHD: the development of the ADHD Star as a framework for multidisciplinary interventions
por: Adamou, Marios, et al.
Publicado: (2016)

Quality of Life in Caregivers of ADHD Children and Diabetes Patients
por: Andrade, Elisa Meirelles, et al.
Publicado: (2016)

47.1 CHALLENGES IN PRESCRIBING AND OPTIMIZING PHARMACOTHERAPY IN ADOLESCENTS WITH ADHD DURING COVID-19
por: Newcorn, Jeffrey H.
Publicado: (2021)

Toward Precision Medicine in ADHD
por: Buitelaar, Jan, et al.
Publicado: (2022)

Comorbidities in ADHD children treated with methylphenidate: a database study
por: Kraut, Angela A, et al.
Publicado: (2013)

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

Electrophysiological evidence for abnormal preparatory states and inhibitory processing in adult ADHD
por: McLoughlin, Gráinne, et al.
Publicado: (2010)

ADHD and Intellectual Disability: using ADHD medication
por: Courtenay, K., et al.
Publicado: (2022)

Services for adults with ADHD: work in progress(†): Commentary on . . . Specialist adult ADHD clinics in East Anglia
por: Coghill, David
Publicado: (2015)

Video Games in ADHD and Non-ADHD Children: Modalities of Use and Association With ADHD Symptoms
por: Masi, Laura, et al.
Publicado: (2021)

Empirical examination of executive functioning, ADHD associated behaviors, and functional impairments in adults with persistent ADHD, remittent ADHD, and without ADHD
por: Roselló, Belén, et al.
Publicado: (2020)

Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
por: Coghill, David R., et al.
Publicado: (2017)

Peripheral Hypoarousal but Not Preparation-Vigilance Impairment Endures in ADHD Remission
por: James, Sarah-Naomi, et al.
Publicado: (2017)

Parent/Caregiver Experiences of a CAMHS ADHD Assessment Pathway: A Qualitative Service Evaluation
por: Kruger, Emily
Publicado: (2023)

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
por: Coghill, David, et al.
Publicado: (2021)

A novel quantitative electroencephalography subtype with high alpha power in ADHD: ADHD or misdiagnosed ADHD?
por: Byeon, Jun, et al.
Publicado: (2020)

Cognitive-electrophysiological indices of attentional and inhibitory processing in adults with ADHD: familial effects
por: McLoughlin, Gráinne, et al.
Publicado: (2011)

Twin and Sibling Studies Using Health Insurance Data: The Example of Attention Deficit/Hyperactivity Disorder (ADHD)
por: Langner, Ingo, et al.
Publicado: (2013)

Impairments in error processing and their association with ADHD symptoms in individuals born preterm
por: Rommel, Anna-Sophie, et al.
Publicado: (2019)

“Late-onset” ADHD symptoms in young adulthood: is this ADHD?
por: Riglin, Lucy, et al.
Publicado: (2022)

Reliability and Validity of the Chen ADHD Scale (C-ADHDS)
por: Chen, Yi-Lung, et al.
Publicado: (2021)

Psychopharmacology of ADHD in pediatrics: current advances and issues
por: Greydanus, Donald E, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_coukvejb1n2cqvbgtgf5709npd